发布求助
文献互助 智能选刊 最新文献

Diabete & metabolisme最新文献

筛选
英文 中文
Effects of infused sodium lactate on glucose and energy metabolism in healthy humans. 灌注乳酸钠对健康人葡萄糖和能量代谢的影响。
Diabete & metabolisme Pub Date : 1995-12-01
N Paquot, P Schneiter, M C Cayeux, R Chiolero, E Temler, E Jequier, L Tappy
{"title":"Effects of infused sodium lactate on glucose and energy metabolism in healthy humans.","authors":"N Paquot,&nbsp;P Schneiter,&nbsp;M C Cayeux,&nbsp;R Chiolero,&nbsp;E Temler,&nbsp;E Jequier,&nbsp;L Tappy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>To assess the effects of lactate on glucose metabolism, sodium lactate (20 mumol.kg-1.min-1) was infused into healthy subjects in basal conditions and during application of a hyperinsulinaemic (6 pmol.kg-1.min-1) euglycaemic clamp. Glucose rate of appearance (GRa) and disappearance (GRd) were measured from plasma dilution of infused U- 13C glucose, and glucose oxidation (G(ox)) from breath 13CO2 and plasma 13C glucose. In basal conditions, lactate infusion did not alter G(ox) (8.8 +/- 0.9 vs 9.2 +/- 1.1 mumol.kg-1.min-1), while GRa slightly decreased from 15.2 +/- 0.8 basal to 13.9 +/- 0.9 mumol.kg-1.min-1 after lactate (p < 0.05). During a hyperinsulinaemic clamp, hepatic glucose production was completely suppressed with or without lactate. Lactate decreased G(ox) from 17.1 +/- 0.4 to 13.4 +/- 1.2 mumol.kg-1.min-1 (p < 0.05), whereas GRd was unchanged (39.7 +/- 3.6 vs 45.6 +/- 2.6 mumol.kg-1.min-1. It is concluded that infusion of lactate in basal conditions does not increase GRa or interfere with peripheral glucose oxidation, and that during hyperinsulinaemia lactate decreases glucose oxidation but does not alter hepatic or peripheral insulin sensitivity.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19565922","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nesidioblastosis and persistent neonatal hyperinsulinism. Nesidioblastosis和持久性新生儿高胰岛素血症。
Diabete & metabolisme Pub Date : 1995-12-01
C Sempoux, F Poggi, F Brunelle, J M Saudubray, C Fekete, J Rahier
{"title":"Nesidioblastosis and persistent neonatal hyperinsulinism.","authors":"C Sempoux,&nbsp;F Poggi,&nbsp;F Brunelle,&nbsp;J M Saudubray,&nbsp;C Fekete,&nbsp;J Rahier","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Neonatal hyperinsulinism is characterized by severe hypoglycaemia which can cause serious neurologic effects. Pancreatic morphological abnormalities involve either focal or diffuse lesions. The former can be cured by resection, whereas the latter, of uncertain pathogenesis, often require subtotal pancreatectomy. We investigated various hypotheses in an effort to explain the origin of this latter form of hyperinsulinism. We determined that nesidioblastosis, long considered to be the basic structural lesion of the diffuse form of hyperinsulinism, is not specific and does not correspond to a continuous proliferation of endocrine cells. We found that an increase in beta-cell mass can be excluded since the volume density of beta cells is not systematically higher in hyperinsulinemic infants than in controls. The hypothesis of a decrease in D cells is attractive but should be considered with due caution since the decrease of the D-cell volume density observed in hypoglycaemic infants is inconstant. Finally, the notion of beta-cell functional abnormality seems the most likely explanation since a higher quantity of proinsulin was detected within the Golgi area by a specific antibody and abnormal nuclei with abundant cytoplasm were observed in some cells. These histological abnormalities can be observed during intraoperative morphological examination. Functional activity might also be evaluated by studying the messenger RNA of proinsulin.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19573877","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Doubly labelled water measurement of total energy expenditure. 双标水测量总能量消耗。
Diabete & metabolisme Pub Date : 1995-10-01
P Ritz, W A Coward
{"title":"Doubly labelled water measurement of total energy expenditure.","authors":"P Ritz,&nbsp;W A Coward","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The doubly labelled water method uses the principles of indirect calorimetry to measure total energy expenditure from the turnover rates of two stable isotopes: deuterium and oxygen 18. Labelling total body water also provides estimates of body composition and measurements of water outflow rates. Although the principle of the method was determined in the 1950s, it was only applied to humans in the 1980s. Some 15 years later, it is time for an objective appraisal of the method. This review first describes the principle and practice of the doubly labelled water method. The original concept described by Lifson and MacClintock is then discussed, and proposals are made to adapt the method to physiological and pathophysiological situations.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas. 胰淀素(胰岛淀粉样蛋白多肽)对非葡萄糖刺激下胰岛素反应的抑制作用。灌注大鼠胰腺的研究。
Diabete & metabolisme Pub Date : 1995-10-01
M Salas, R A Silvestre, O Garcia-Hermida, T Fontela, J Rodriguez-Gallardo, J Marco
{"title":"Inhibitory effect of amylin (islet amyloid polypeptide) on insulin response to non-glucose stimuli. Study in perfused rat pancreas.","authors":"M Salas,&nbsp;R A Silvestre,&nbsp;O Garcia-Hermida,&nbsp;T Fontela,&nbsp;J Rodriguez-Gallardo,&nbsp;J Marco","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Amylin, also called islet amyloid polypeptide (IAPP), can inhibit the glucose-induced insulin secretion in perfused rat pancreas at 75 pmol/l, a concentration comparable to that found in the effluent of this experimental model. To further explore the influence of amylin on insulin release, we investigated the effect of synthetic rat amylin (75 pmol/l) on insulin response to non-glucose secretagogues. These agents stimulate B-cell secretion via different mechanisms, such as a dihydropyridine derivative (BAY K 8644, 10 mmol/l) which activates Ca(2+)-channels, a sulfonylurea (tolbutamide, 0.2 mmol/l) which blocks ATP-dependent K(+)-channels, KCL (11 mmol/l) which depolarizes B cells and the 26-33 fragment of cholecystokinin (8-CCK, 1 nmol/l) which increases phospholipid turnover. The study was performed in perfused rat pancreas. Amylin significantly inhibited insulin response to BAY K 8644 (65%), KCI (60%) and 8-CCK (80%) as well as the early phase of tolbutamide-induced insulin output (70%). Thus, amylin can inhibit insulin release induced by secretagogues that interact at different levels of B-cell stimulus-secretion coupling. This inhibition may be due to a multifarious influence of amylin on the B-cell secretory mechanism and/or a disturbing effect on a distal, crucial step in the insulin-releasing mechanism, e.g. by affecting exocytosis of the secretory granule or by inhibiting an essential metabolic pathway within the B cell.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low-cost measurement of body composition with 18O-enriched water. 用富氧水低成本测量人体成分。
Diabete & metabolisme Pub Date : 1995-10-01
C Vache, P Gachon, M Ferry, B Beaufrere, P Ritz
{"title":"Low-cost measurement of body composition with 18O-enriched water.","authors":"C Vache,&nbsp;P Gachon,&nbsp;M Ferry,&nbsp;B Beaufrere,&nbsp;P Ritz","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Total body water (TBW) and body composition are crucial for the estimation of nutritional status in many clinical circumstances. While the measurement of TBW with 18O-enriched water is technically easier than with 2H2O, the cost of 10% 18O-enriched water can be regarded as prohibitive. The aim of this study was to prove that less enriched (i.e. 2%) and cheaper (about 25 ECU per dose per subject, i.e. $30) 18O water can be used to measure TBW. In the 41 subjects studied, isotopic equilibrium was achieved 4 hours after the isotope was administered. Plateau enrichments in urine, saliva, and plasma samples did not differ significantly between 5 and 8 hours after the dose. TBW measurements in 8 of these subjects showed no significant differences, regardless of whether 2% or 10% water was used. We conclude that accurate estimates of TBW and body composition can be obtained with low-cost, 2% 18O-enriched water.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Use of insulin in non-insulin-dependent diabetes (diabetes type 2). Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)]. [胰岛素在非胰岛素依赖型糖尿病(2型糖尿病)中的使用。ALFEDIAM(法语糖尿病和代谢疾病研究协会)的建议]。
Diabete & metabolisme Pub Date : 1995-10-01
J M Brun, G Cathelineau, B Charbonnel, P Drouin, V Durlach, P Fontaine, P J Guillausseau, S Halimi, P Vexiau, B Vialettes
{"title":"[Use of insulin in non-insulin-dependent diabetes (diabetes type 2). Recommendations of ALFEDIAM (French Language Association for the Study of Diabetes and Metabolic Diseases)].","authors":"J M Brun,&nbsp;G Cathelineau,&nbsp;B Charbonnel,&nbsp;P Drouin,&nbsp;V Durlach,&nbsp;P Fontaine,&nbsp;P J Guillausseau,&nbsp;S Halimi,&nbsp;P Vexiau,&nbsp;B Vialettes","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511464","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus. 健康受试者和非胰岛素依赖型糖尿病患者肝糖生成的调节
Diabete & metabolisme Pub Date : 1995-10-01
L Tappy
{"title":"Regulation of hepatic glucose production in healthy subjects and patients with non-insulin-dependent diabetes mellitus.","authors":"L Tappy","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The regulation of endogenous glucose production is central to the control of blood glucose concentrations. In non-insulin-dependent diabetes mellitus (NIDDM), increased endogenous glucose production contributes to fasting hyperglycaemia. Gluconeogenesis appears to be exaggerated in NIDDM, and it may be hypothesized that an enhanced release of gluconeogenic precursors is responsible for increased total glucose output. However, it would appear that substrate-induced stimulation of gluconeogenesis fails to increase total glucose production in healthy humans and NIDDM patients. This autoregulation of endogenous glucose production may be attained by inhibition of glycogenolysis and/or gluconeogenesis from endogenous substrate. It has also been observed that stimulation of intrahepatic disposal of neoformed glucose (mainly as glycogen synthesis) contributes to autoregulation. These observations support the concept that intrahepatic disposal of glucose-6-phosphate plays a major role in the control of endogenous glucose production.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes. 胰岛素受体酪氨酸激酶活性的变化与二甲双胍治疗2型糖尿病相关。
Diabete & metabolisme Pub Date : 1995-10-01
R F Santos, R Nomizo, B L Wajhenberg, G M Reaven, S Azhar
{"title":"Changes in insulin receptor tyrosine kinase activity associated with metformin treatment of type 2 diabetes.","authors":"R F Santos,&nbsp;R Nomizo,&nbsp;B L Wajhenberg,&nbsp;G M Reaven,&nbsp;S Azhar","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This study was performed to define the effect of metformin on glycaemic control and erythrocyte insulin receptor tyrosine kinase activity in patients with non-insulin-dependent (Type 2) diabetes mellitus. A case-control study of the effect of metformin treatment in hyperglycaemic patients with Type 2 diabetes was conducted in outpatients of the Diabetes Clinical Center. The study population consisted of 14 patients with Type 2 diabetes (5 males, 9 females) whose hyperglycaemia was uncontrolled by diet. Patients were treated with metformin 850 mg twice daily for 2 1/2 months. Fasting plasma glucose concentrations decreased from 8.9 to 6.4 mmol/L after 10 weeks of metformin treatment (p < 0.001), in association with significantly lower (p < 0.001) plasma glucose and insulin concentrations in response to an oral glucose load. In addition, both fasting plasma triglyceride and cholesterol concentrations were significantly (p < 0.001) lower after metformin treatment. There was no change in erythrocyte insulin receptor binding associated with metformin treatment, but both basal and insulin-stimulated insulin receptor tyrosine kinase activities of solubilized erythrocyte insulin receptors were significantly higher after 10 weeks of metformin treatment. It is concluded that the increase in insulin-stimulated tyrosine kinase activity contributed to the improvement in glucose insulin and lipoprotein metabolism associated with metformin treatment of Type 2 diabetes.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Microalbuminuria and non-insulin-dependent diabetes: practical interpretation and therapeutic consequences]. [微量白蛋白尿和非胰岛素依赖型糖尿病:实际解释和治疗后果]。
Diabete & metabolisme Pub Date : 1995-10-01
B Bouhanick, G Berrut, P Fressinaud, M Marre
{"title":"[Microalbuminuria and non-insulin-dependent diabetes: practical interpretation and therapeutic consequences].","authors":"B Bouhanick,&nbsp;G Berrut,&nbsp;P Fressinaud,&nbsp;M Marre","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk factors and their identification. Third Part: Examples. 风险因素及其识别。第三部分:例子。
Diabete & metabolisme Pub Date : 1995-10-01
B Balkau, E Eschwege
{"title":"Risk factors and their identification. Third Part: Examples.","authors":"B Balkau,&nbsp;E Eschwege","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>This is the final of a series of three articles in Diabete & Metabolisme which reviews the identification of risk factors of a disease, here: diabetes or complications of diabetes. In the first of the series [1], we gave the definition of a risk factor, along with measures of its force-relative risk and odds ratio, followed by the epidemiological definitions of the diseases: diabetes, coronary heart disease and hypertension. Risk factors were further discussed and we completed the discussion by some observations on the bias which can arise from a study or from its analysis, which can lead the researcher to the wrong conclusion. The three types of epidemiological studies which are used to determine whether factors are associated with a disease: observational or cross-sectional studies, cohort studies and case-cohort studies are described in the second of the series [2]. Examples were provided of each of these study types and their advantages and disadvantages were discussed. This final paper provides some examples of the study types and the identification of risk factors from the literature. The first examples involve diabetes and pancreatic cancer, the second birth weight and non-insulin dependent diabetes. Having found an association between a risk factor and a disease, we then discuss whether it can be considered to be a risk factor, and if so and whether it is likely to be a cause of the disease.</p>","PeriodicalId":11111,"journal":{"name":"Diabete & metabolisme","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1995-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"19511466","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信